Posted in | News | Iron Ore

Cap-Ex Drill Announces Assay Results from Block 103 Iron Property

Cap-Ex Ventures has declared the assay results for three holes from the Northwest Zone on the Block 103 iron property situated roughly 30 km northwest of Schefferville’s mining town in Quebec.

All the holes intercepted substantial iron mineralization. The holes DDH103-17, DDH103-16 and DDH103-12 intercepted 30.6% of total iron from 48.2 m, 31.0% of total iron from 29.6 m, and 31.5% of total iron from 4.9 m, respectively.

The Northwest Zone is situated 2 km towards the Greenbush Zone’s west. A total of six holes were diamond drill tested at the Northwest Zone over 5.3 km of strike, and drill spacing varied from 200-2,100 m. These six holes encountered mineralization with a total iron grade of over 31%. The Northwest Zone is slightly plunging northeast, striking northwest to southeast and remains exposed to the south from where the width increases from 90.6 to 148.4 m. The Block 103's north boundary has confined the northern strike extension. The supposed width ranges from 0.5 to 1.5 km and contacts the Kivivic Lake to the east. The Block 103’s west boundary confines this width. The mineralization in DDH103-17 hole is exposed at depth.

The Northwest Zone is on strike between the KeMag and LabMag deposits on the adjoining properties owned by New Millenium Iron, which had earlier stated that the ore bodies represent a continuous zone of mineralization. The identification of mineralization at the Northwest Zone may support this notion.

In the coming season, Cap-Ex Ventures has planned to drill test the Northwest Zone’s southern strike extension till the property boundary. The company anticipates receiving further 2011 drill assay results for the Greenbush Zone located in Block 103.

Francois Laurin, Cap-Ex President and CEO, informed that the company has developed an exploration program and plans to release a preliminary mineral resource estimate by 2012 end as well as a preliminary economic evaluation by Q1 of 2013.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 18). Cap-Ex Drill Announces Assay Results from Block 103 Iron Property. AZoMining. Retrieved on November 10, 2024 from https://www.azomining.com/News.aspx?newsID=5930.

  • MLA

    Scanlon, Joel. "Cap-Ex Drill Announces Assay Results from Block 103 Iron Property". AZoMining. 10 November 2024. <https://www.azomining.com/News.aspx?newsID=5930>.

  • Chicago

    Scanlon, Joel. "Cap-Ex Drill Announces Assay Results from Block 103 Iron Property". AZoMining. https://www.azomining.com/News.aspx?newsID=5930. (accessed November 10, 2024).

  • Harvard

    Scanlon, Joel. 2019. Cap-Ex Drill Announces Assay Results from Block 103 Iron Property. AZoMining, viewed 10 November 2024, https://www.azomining.com/News.aspx?newsID=5930.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.